- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03442127
Facilitating Oncology Patient-Clinician Communication Via E-health Innovations
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Nebraska
-
Omaha, Nebraska, United States, 68131
- University of Nebraska Medical Center, Oncology Clinics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- first, stage I - IV breast cancer
- have had at least 1 appointment with a medical oncologist with additional -appointments planned at University of Nebraska Medical Center/Nebraska Medicine clinics,
- able to read and speak English,
- have regular access to Internet and computer,
- have email
Exclusion Criteria:
- Male,
- mentally or physically unable to consent or use the CaringGuidance program (e.g. hospitalized in the past year with a substance abuse or mental health condition)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Patient Group
Program users
|
Web-based, psychoeducational, self-management tool
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Satisfaction with the Content of the CaringGuidance Summary Report Form
Time Frame: 1 minute
|
qualitative description from the patient regarding their satisfaction with the content of the CaringGuidance Summary Report
|
1 minute
|
|
Functionality of the CaringGuidance Summary Report Form
Time Frame: 10 minutes
|
qualitative description of the functioning of the CaringGuidance Summary Report
|
10 minutes
|
|
Usability of the CaringGuidance Summary Report From
Time Frame: 20 minutes
|
quantitative measure of usability of the form by the System Usability Scale a 10 item scale (strongly disagree to strongly agree) developed by John Brookes 1986 at Digital Equipment Corporation and used in multiple studies.The participant's scores for each question are converted to a new number, added together and then multiplied by 2.5 to convert the original scores of 0-40 to 0-100. Though the scores are 0-100, these are not percentages and should be considered only in terms of their percentile ranking. Based on research, a System Usability Scale score above a 68 would be considered above average and anything below 68 is below average, however the best way to interpret your results involves "normalizing" the scores to produce a percentile ranking. |
20 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient-clinician communication using CaringGuidance Summary Report Form
Time Frame: during clinical encounter, approximately 20 minutes
|
qualitative description of psychosocial topics discussed
|
during clinical encounter, approximately 20 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Robin M Lally, PhD, RN, University of Nebraska
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 0432-17-EP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.